lung health
Arrotex bolsters pharmacy offering
Following the merger of Apotex and Arrow, the combined Arrotex entity now has a considerable portfolio of respiratory medicines – including two new products Arrotex Pharmaceuticals has announced a strategic …
‘Burning throats, difficulty breathing and burning eyes.’
Sydney pharmacists have been working overtime after the city was hit with an air quality index ten times the ‘hazardous’ level on Tuesday After weeks of haze covering Sydney due …
Bushfires spark breathing concerns and asthma warning
The National Asthma Council Australia is cautioning Australians that bushfires raging throughout the country are putting lives at risk from asthma It is vital for anyone with asthma living in …
One in eight: tobacco fatalities in Australia
Tobacco use contributed to around 21,000 deaths in 2015 – though the rate of disease burden is falling But the burden linked to past smoking rose by 15%, the new …
Research Roundup
Debbie Rigby rounds up the latest in research news Atrial Fibrillation and Chronic Kidney Disease Analysis of registry data in GARFIELD‐AF shows moderate‐to‐severe CKD was independently associated with stroke/systemic embolism, …
Dust warning
With dust storms descending on the ACT and parts of NSW, NPS MedicineWise has reminded people to keep taking their medicines People with heart or breathing conditions need to follow …
Clinical tips: COPD
Louis Roller takes a look at COPD and practice points for pharmacists “When you can’t breathe … nothing else matters” COPD is characterised by airflow limitation that is not fully …
Clinical tips: asthma
Asthma is much more than just the wheeze when symptoms appear, writes Louis Roller More than two million Australians have asthma – about one in 10 adults and about one …
Sildenafil trial halted as babies die
A trial of sildenafil in pregnant women has been stopped after eleven babies died The Amsterdam University Medical Centre has confirmed that it has stopped a study of the effect …
Research Roundup
Debbie Rigby rounds up the latest in research news Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults In a large cohort of older adults in primary care, …
Triple therapy for COPD superior: study
New research published in the New England Journal of Medicine has shown triple therapy better reduces moderate/severe exacerbations compared with dual therapy Results from the IMPACT study, one of the …
How pollution cancels cardiovascular benefits
Exposure to traffic fumes may negate any heart and lung benefits of walking among older adults A new UK study examined how even short-term exposure to tiny particles of soot …